Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989598825> ?p ?o ?g. }
- W2989598825 endingPage "545" @default.
- W2989598825 startingPage "533" @default.
- W2989598825 abstract "Gaining full benefits from osteoporosis medications requires long-term treatment. Investigating the real-world persistence of women receiving osteoporosis medications in the UK, we found that most patients stop treatment within a year. To prevent osteoporotic fragility fractures, long-term treatment persistence must be improved. Persistence with osteoporosis therapies has historically been poor. To treat this chronic and progressive disease, it is essential that patients receive the full benefit of these medications. We estimated persistence and compliance with osteoporosis therapies in a large sample of postmenopausal women in the UK. Data were obtained from the Clinical Practice Research Datalink for all women aged 50 years and over or women with early menopause, who received at least one prescription in primary care for any licensed osteoporosis therapy between January 1, 2010 and December 31, 2015. Persistence and compliance at 24 months (primary objective) and at 5 years (exploratory objective) were estimated in three patient cohorts: “All Patients,” “Naïve Patients,” and “Drug-Specific.” The All Patients cohort included 72,256 women. Persistence with any therapy was 56.1%, 43.6%, 36.4%, and 31.0% at 6, 12, 18, and 24 months, respectively, and 23.2% and 13.1% at 3 years and 5 years, respectively. Patients were generally more persistent and compliant if evaluated from their first exposure to osteoporosis therapy (Naïve Patients cohort). In the drug-specific analysis, 64% of patients receiving denosumab (administered subcutaneously every 6 months) were persistent at 24 months compared with 28% and 23% of those taking oral bisphosphonates and intravenous bisphosphonates, respectively. Only about one in three patients who received osteoporosis therapy continued to be on treatment after 2 years. There is a need to improve persistence with osteoporosis therapy, especially for high-risk patients" @default.
- W2989598825 created "2019-12-05" @default.
- W2989598825 creator A5008946542 @default.
- W2989598825 creator A5013374962 @default.
- W2989598825 creator A5046972046 @default.
- W2989598825 creator A5061938750 @default.
- W2989598825 creator A5078328291 @default.
- W2989598825 creator A5085012338 @default.
- W2989598825 creator A5086808123 @default.
- W2989598825 date "2019-11-22" @default.
- W2989598825 modified "2023-10-16" @default.
- W2989598825 title "Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink" @default.
- W2989598825 cites W1519774985 @default.
- W2989598825 cites W1755735910 @default.
- W2989598825 cites W1789637994 @default.
- W2989598825 cites W1916448504 @default.
- W2989598825 cites W1961375326 @default.
- W2989598825 cites W1976384386 @default.
- W2989598825 cites W1979131124 @default.
- W2989598825 cites W1984754135 @default.
- W2989598825 cites W1988975076 @default.
- W2989598825 cites W1992753345 @default.
- W2989598825 cites W1998033364 @default.
- W2989598825 cites W2002978740 @default.
- W2989598825 cites W2006452622 @default.
- W2989598825 cites W2021748249 @default.
- W2989598825 cites W2028209514 @default.
- W2989598825 cites W2032093049 @default.
- W2989598825 cites W2041055356 @default.
- W2989598825 cites W2074724534 @default.
- W2989598825 cites W2079396916 @default.
- W2989598825 cites W2107177524 @default.
- W2989598825 cites W2118100789 @default.
- W2989598825 cites W2119852447 @default.
- W2989598825 cites W2134227600 @default.
- W2989598825 cites W2139062201 @default.
- W2989598825 cites W2213850234 @default.
- W2989598825 cites W2319932633 @default.
- W2989598825 cites W2382318563 @default.
- W2989598825 cites W2525760994 @default.
- W2989598825 cites W2569402022 @default.
- W2989598825 cites W2592667725 @default.
- W2989598825 cites W2622210331 @default.
- W2989598825 cites W2688671099 @default.
- W2989598825 cites W2734562071 @default.
- W2989598825 cites W2789274247 @default.
- W2989598825 doi "https://doi.org/10.1007/s00198-019-05228-8" @default.
- W2989598825 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7076063" @default.
- W2989598825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31758206" @default.
- W2989598825 hasPublicationYear "2019" @default.
- W2989598825 type Work @default.
- W2989598825 sameAs 2989598825 @default.
- W2989598825 citedByCount "33" @default.
- W2989598825 countsByYear W29895988252020 @default.
- W2989598825 countsByYear W29895988252021 @default.
- W2989598825 countsByYear W29895988252022 @default.
- W2989598825 countsByYear W29895988252023 @default.
- W2989598825 crossrefType "journal-article" @default.
- W2989598825 hasAuthorship W2989598825A5008946542 @default.
- W2989598825 hasAuthorship W2989598825A5013374962 @default.
- W2989598825 hasAuthorship W2989598825A5046972046 @default.
- W2989598825 hasAuthorship W2989598825A5061938750 @default.
- W2989598825 hasAuthorship W2989598825A5078328291 @default.
- W2989598825 hasAuthorship W2989598825A5085012338 @default.
- W2989598825 hasAuthorship W2989598825A5086808123 @default.
- W2989598825 hasBestOaLocation W29895988251 @default.
- W2989598825 hasConcept C126322002 @default.
- W2989598825 hasConcept C127413603 @default.
- W2989598825 hasConcept C1862650 @default.
- W2989598825 hasConcept C187212893 @default.
- W2989598825 hasConcept C187320778 @default.
- W2989598825 hasConcept C198451711 @default.
- W2989598825 hasConcept C201903717 @default.
- W2989598825 hasConcept C2426938 @default.
- W2989598825 hasConcept C2776286101 @default.
- W2989598825 hasConcept C2776541429 @default.
- W2989598825 hasConcept C2778562196 @default.
- W2989598825 hasConcept C2781009140 @default.
- W2989598825 hasConcept C71924100 @default.
- W2989598825 hasConcept C72563966 @default.
- W2989598825 hasConcept C98274493 @default.
- W2989598825 hasConceptScore W2989598825C126322002 @default.
- W2989598825 hasConceptScore W2989598825C127413603 @default.
- W2989598825 hasConceptScore W2989598825C1862650 @default.
- W2989598825 hasConceptScore W2989598825C187212893 @default.
- W2989598825 hasConceptScore W2989598825C187320778 @default.
- W2989598825 hasConceptScore W2989598825C198451711 @default.
- W2989598825 hasConceptScore W2989598825C201903717 @default.
- W2989598825 hasConceptScore W2989598825C2426938 @default.
- W2989598825 hasConceptScore W2989598825C2776286101 @default.
- W2989598825 hasConceptScore W2989598825C2776541429 @default.
- W2989598825 hasConceptScore W2989598825C2778562196 @default.
- W2989598825 hasConceptScore W2989598825C2781009140 @default.
- W2989598825 hasConceptScore W2989598825C71924100 @default.
- W2989598825 hasConceptScore W2989598825C72563966 @default.
- W2989598825 hasConceptScore W2989598825C98274493 @default.
- W2989598825 hasIssue "3" @default.
- W2989598825 hasLocation W29895988251 @default.